Uffing, Audrey
Pérez-Sáez, Maria José
La Manna, Gaetano
Comai, Giorgia
Fischman, Clara
Farouk, Samira
Manfro, Roberto Ceratti
Bauer, Andrea Carla
Lichtenfels, Bruno
Mansur, Juliana B.
Tedesco-Silva, Hélio
Kirsztajn, Gianna M.
Manonelles, Anna
Bestard, Oriol
Riella, Miguel Carlos
Hokazono, Silvia Regina
Arias-Cabrales, Carlos
David-Neto, Elias
Ventura, Carlucci Gualberto
Akalin, Enver
Mohammed, Omar
Khankin, Eliyahu V.
Safa, Kassem
Malvezzi, Paolo
O’Shaughnessy, Michelle Marie
Cheng, Xingxing S.
Cravedi, Paolo
Riella, Leonardo V.
Article History
Received: 6 December 2017
Accepted: 28 August 2018
First Online: 12 September 2018
Ethics approval and consent to participate
: The protocol of phase 1 of TANGO-study was submitted and approved by the Partners Human Research Committee (PHRC), (protocol number 2015P000993) and at each participating center. Documents of approval have been provided to BMC Nephrology. In one center, the University Medical Center Groningen, ethical approval was waived by the Medical Ethics review Board (METc UMCG). For retrospective data collection during phase 1 of the TANGO-study, written consent was waived in all centers. For phase 2, a biobanking protocol was also submitted and approved by the PHRC at the Brigham and Women’s hospital in Boston (protocol number 2017P000298). Ethical approval of sample collection at other centers is currently ongoing. Each center will aim to obtain IRB approval for prospective data and sample collection, and sharing across the TANGO centers. Patients will have to be consented to participate in this phase of the study.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.